Management of Distally Extension Maxillary Atrophied Ridge With Two Different Minimal Invasive Treatment Modalities

Launched by MANSOURA UNIVERSITY · Dec 9, 2022

Keywords

ClinConnect Summary

Patient selection:

For this study, 40 patients were selected from the clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University.

Inclusion criteria:

The patients will be selected according to the following:

* They have atrophied unilateral distal extension maxillary ridge and remaining alveolar bone height 6- 8 mm as verified by preoperative cone beam. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory i...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * The patients will be selected according to the following:
• • They have atrophied unilateral distal extension maxillary ridge and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
• • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
• • Patients are less satisfied with conventional RPD.
• • Absence of maxillary sinus diseases.
• Exclusion Criteria:
• • • Acute or chronic sinus pathology
• • History of a sinus augmentation in the past in the relevant sinus
• • Poor dental hygiene. Smoker.
• • Compromised general health (uncontrolled diabetes, bleeding disorder